Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B- 17

Journal of Clinical Oncology

Volumn 16, Issue 2, 1998, Pages 441-452

  Fisher, Bernard ^a   Dignam, James ^a   Wolmark, Norman ^a   Mamounas, Eleftherios ^a   Costantino, Joseph ^a   Poller, William ^a   Fisher, Edwin R ^a   Wickerham, D Lawrence ^a   Deutsch, Melvin ^a   Margolese, Richard ^a   Dimitrov, Nikolay ^a   Kavanah, Maureen ^a  

^a National Surgical Adjuvant Breast and Bowel Project Operations and Statistical Centers   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT THERAPY; ARTICLE; BREAST CARCINOMA; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CARCINOMA IN SITU; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL CARCINOMA; MAMMOGRAPHY; PARTIAL MASTECTOMY; PRIORITY JOURNAL; RISK BENEFIT ANALYSIS; TREATMENT OUTCOME;

EID: 0031941704     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.2.441     Document Type: Article

References (33)

1. Swanson GM, Ragheb NE, Lin CS, et al: Breast cancer among black and white women in the 1980s: Changing patterns in the United States by race, age and extent of disease. Cancer 72:788-798, 1993
2. Berg JW, Hutter RV: Breast cancer. Cancer 75:257-269, 1995
3. Ernster VL, Barclay J, Kerlikowske K, et al: Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA 275:913-918, 1996
4. Choi WS, Parker BA, Pierce JP, et al: Regional differences in the incidence and treatment of carcinoma in situ of the breast. Cancer Epidemiol Biomark Prev 5:317-320, 1996
5. Fisher B, Costantino J, Redmond C, et al: Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 328:1581-1586, 1993
6. Silverstein MJ, Rosser RJ, Gierson ED, et al: Axillary lymph node dissection for intraductal breast carcinoma - Is it indicated? Cancer 59:1819-1824, 1987
7. Fisher B, Bauer M, Margolese R, et al: Five-year results of a randomized clinical trial comparing total mastectomy and segmental mastectomy with or without radiation in the treatment of breast cancer. N Engl J Med 312:665-673, 1985
8. Fisher B, Wolmark N, Fisher ER, et al: Lumpectomy and axillary dissection for breast cancer: Surgical, pathological, and radiation considerations. World J Surg 9:692-698, 1985
9. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
10. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
11. Cox DR: Regression models and life-tables. J R Stat Soc B 34:187-220, 1972
12. Prentice RL, Kalbfleish JD, Peterson AV, et al: The analysis of failure times in the presence of competing risks. Biometrics 34:541-554, 1978
13. Gaynor JJ, Feuer EJ, Tan CC, et al: On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data. J Am Stat Assoc 88:400-409, 1993
14. Lagios MD: Duct carcinoma in situ: Biological implications for clinical practice. Semin Oncol 23:6-11, 1996(suppl 2)
15. Solin LJ, Recht A, Fourquet A, et al: Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma (ductal carcinoma in situ) of the breast. Cancer 68:2337-2344, 1991
16. Solin LJ, Yeh I-T, Kurtz J, et al: Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast-conserving surgery and definitive irradiation: Correlation of pathologic parameters with outcome of treatment. Cancer 71:2532-2542, 1993
17. Silverstein MJ, Poller DN, Waisman JR, et al: Prognostic classification of breast ductal carcinoma-in-situ. Lancet 345:1154-1157, 1995
18. Bomstein BA, Recht A, Connolly JL, et al: Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 67:7-13, 1991
19. Silverstein MJ: Noninvasive breast cancer: The dilemma of the 1990s. Obstet Gynecol Clin North Am 21:639-658, 1994
20. McCormick B: Panel session, at the 36th Annual Meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO), San Francisco CA. Reported by R Brylawski. DCIS: Sorting out the known from the unknown. Oncology Times, January 17, 1995
21. Page DL, Lagios MD: Pathologic analysis of the National Surgical Adjuvant Breast Project (NSABP). Cancer 75:1219-1222, 1995
22. Hillner BE, Desch CE, Carlson RW, et al: Trade-offs between survival and breast preservation for three initial treatments of ductal carcinoma in-situ of the breast. J Clin Oncol 14:70-77, 1996
23. Page DL, Jensen RA: Ductal carcinoma in situ of the breast: Understanding the misunderstood stepchild. JAMA 275:948-949, 1996
24. Silverstein MJ, Lagios MD, Craig PH, et al: A prognostic index for ductal carcinoma in situ of the breast. Cancer 77:2267-2274, 1996
25. Swallow CJ, Van Zee KJ, Sacchini V, et al: Ductal carcinoma in situ of the breast: Progress and controversy. Curr Probl Surg 33:555-599, 1996
26. Fisher ER, Costantino J, Fisher B, et al: Pathologic findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-17: Intraductal carcinoma (duct carcinoma in situ). Cancer 75:1310-1319, 1995
27. Fisher ER, Costantino J, Fisher B, et al: Response - Blunting the counterpoint. Cancer 75:1223-1227, 1995
28. Fisher ER: Pathobiological considerations relating to the treatment of intraductal carcinoma (ductal carcinoma in situ) of the breast. CA 47:52-64, 1996
29. Schnitt SJ, Harris JR, Smith BL: Developing a prognostic index for ductal carcinoma in situ of the breast. Are we there yet? Cancer 77:2189-2192, 1996
30. Fisher ER: The National Surgical Adjuvant Breast Project (NSABP) experience: Pathology, in Silverstein MS (ed): Ductal Carcinoma in Situ of the Breast. Baltimore, MD, Williams & Wilkins, 1997, pp 259-269
31. Balch CM, Singletary SE, Bland KI: Clinical decision-making in early breast cancer. Ann Surg 217:207-225, 1993
32. Fowble B: Intraductal noninvasive breast cancer: A comparison of three local treatments. Oncology 3:51-58, 1989
33. Webber BL, Heise BS, Neifeld JP, et al: Risk of subsequent contralateral breast carcinoma in a population of patients with in-situ breast carcinoma. Cancer 47:2928-2932, 1981